Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer’s Disease in EXPEDITION 3

被引:0
作者
Hong Liu-Seifert
E. Siemers
K. Sundell
M. Mynderse
J. Cummings
R. Mohs
P. Aisen
机构
[1] Lilly Research Laboratories,Alzheimer’s Therapeutic Research Institute
[2] Lilly Corporate Center,undefined
[3] Syneos Health,undefined
[4] Cleveland Clinic Lou Ruvo Center for Brain Health,undefined
[5] formerly of Lilly Research Laboratories,undefined
[6] Lilly Corporate Center,undefined
[7] University of Southern California,undefined
[8] Eli Lilly and Company,undefined
[9] Lilly Corporate Center,undefined
来源
The Journal of Prevention of Alzheimer's Disease | 2018年 / 5卷
关键词
Cognition; function; Alzheimer’s disease; correlation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:184 / 187
页数:3
相关论文
共 36 条
[1]  
Montine TJ(2012)National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach Acta Neuropathol 123 1-11
[2]  
Phelps CH(2011)The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 270-279
[3]  
Beach TG(2016)Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria Alzheimers Dement 12 292-323
[4]  
Albert MS(2011)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 263-269
[5]  
DeKosky ST(2015)Cognitive impairment precedes and predicts functional impairment in mild Alzheimer’s disease J Alzheimers Dis 47 205-214
[6]  
Dickson D(2015)Cognitive and functional decline and their relationship in patients with mild Alzheimer’s dementia J Alzheimers Dis 43 949-955
[7]  
Dubois B(2016)Correlation between Cognition and function across the spectrum of Alzheimer’s disease J Prev Alzheimers Dis 3 138-144
[8]  
Hampel H(2013)Cognitive declines precede and predict functional declines in aging and Alzheimer’s disease PLoS One 8 73645-321
[9]  
Feldman HH(2014)Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease N Engl J Med 370 311-S21
[10]  
McKhann GM(1997)Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord 11 S13-S39